Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Ranbaxy Laboratories Ltd. Company Profile

10:45 EDT 21st April 2014 | BioPortfolio

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 46 countries and manufacturing operations in 7 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit

News Articles [514 Associated News Articles listed on BioPortfolio]

Ranbaxy Laboratories also looking to sell its vaccine business

Drug maker Ranbaxy Laboratories is likely to sell off Biovel, a Bangalore-based vaccine manufacturing company which it had acquired in 2010. Although Ranbaxy made the acquisition to foray into the...

Update-Moody's: Daiichi Sankyo Will Benefit from Sun Pharma's Acquisition of Ranbaxy

Sun Pharmaceutical Industries Ltd (Sun Pharma) & Ranbaxy Laboratories Ltd (Ranbaxy)

Sun Pharma to acquire Ranbaxy Laboratories for $3.2bn

Sun Pharmaceutical has entered into definitive agreement to acquire Ranbaxy Laboratories in an all-stock transaction totalling equity value of $3.2bn.

Under fire Ranbaxy sold to Sun Pharma for $4 billion

Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become one of the biggest in their native India. Sun has agreed to acquire...

Sun Pharma and Ranbaxy engage in M&A transaction

Sun Pharmaceutical agreed to m&a transaction to buy competitor Ranbaxy Laboratories for $3.2 billion from Japan’s Daiichi Sankyo, which paid 61 percent more for the company five years ago. Ranba...

Sun Pharma Seeks To Add 28% To Ranbaxy Stake In Zenotech Labs

Sun Pharmaceutical Industries has turned its investment interest to another India drug maker, Zenotech Laboratories in which Ranbaxy Laboratories has a 46.8% stake.

Ranbaxy stock rallies after case settled with New York attorney general

Shares of Ranbaxy Laboratories Ltd rose as much as 4.39% to Rs.366.35 a unit on BSE on Wednesday after the drug maker settled an anti-competition case in the US. Ranbaxy,...

Ranbaxy sues Actavis over generic acne drug

Indian generics giant Ranbaxy Laboratories (Ranbaxy) is suing US generic drugmaker Actavis to try to stop the latter marketing a generic version of Ranbaxy’s acne drug Absorica (isotretinoin).

Drugs and Medications [431 Associated Drugs and Medications listed on BioPortfolio]

Desquam-x wash [Ranbaxy Laboratories Inc.]


Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Clindamycin hydrochloride [RedPharm Drug Inc.]

Eurax [Ranbaxy Laboratories Inc.]


PubMed Articles [123 Associated PubMed Articles listed on BioPortfolio]

Assessment of Microbiological Diagnostic Procedures for Respiratory Specimens from Cystic Fibrosis Patients in German Laboratories by a Questionnaire.

Respiratory specimens of cystic fibrosis (CF) patients challenge microbiological laboratories with their complexity of pathogens and atypical variants. We evaluated the diagnostic procedures in German...

Impact of Proficiency Testing Program for Laboratories Conducting Early Infant Diagnosis of HIV-1 in Low to Middle-Income Countries.

A voluntary, cost-free external quality assessment (EQA) program established by the U.S. Centers for Disease Control and Prevention (CDC) was implemented to primarily monitor the performance of labora...

Critical value reporting: A survey of 36 clinical laboratories in South Africa.

Objective. Critical value policies are used by clinical laboratories to decide when to notify caregivers of life-threatening results. Despite their widespread use, critical value policies have not bee...

Incidents in reposition of smallpox virus laboratories and its retrospect and ponderation.

Reposition of variola virus in some laboratories in the UK led to some serious incidents before the announcement by WHO of the Global Eradication of Smallpox in 1980. These three incidents resulted in...

Impact of Changes in Clostridium difficile Testing Practices on Stool Rejection Policies and C. difficile Positivity Rates across Multiple Laboratories in the United States.

We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laborator...

Clinical Trials [177 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following admin...

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

This open-label, balanced, randomized, two-treatment, four-period, two-sequence, single dose, crossover fully replicated study was conducted on fixed-dose combination of quinapril 20 mg an...

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

The objective of this study was to compare the single-dose oral bioavailability of Carvedilol 12.5 mg tablets of Ranbaxy Laboratories with Coreg 12.5 mg tablets of Glaxosmithkline in healt...

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

The objective of this study is to compare the relative bioavailability of glimepiride 1 mg tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets (follow...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet...

Companies [858 Associated Companies listed on BioPortfolio]

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, aff...

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality,...

Sterling Rasayan (P) Ltd

In less than twenty years, Sterling through its professional approach and innovative marketing strategy has been able to cater to the requirements of many prestigious customers from local producers t...


Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Ranbaxy Laboratories Ltd." on BioPortfolio

We have published hundreds of Ranbaxy Laboratories Ltd. news stories on BioPortfolio along with dozens of Ranbaxy Laboratories Ltd. Clinical Trials and PubMed Articles about Ranbaxy Laboratories Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ranbaxy Laboratories Ltd. Companies in our database. You can also find out about relevant Ranbaxy Laboratories Ltd. Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record